Because these medications often reduce food intake, it becomes easier to fall short on key nutrients
Investment Thesis GLP-1s, also known as glucagon-like peptide-1, is a medication used for weight loss and diabetes management
Contraindications:: Patients with a personal or family history of medullary thyroid carcinoma (based upon animal data - see FDA Warning) History of hypersensitivity to semaglutide or any of its excipients (serious reactions including angioedema & anaphylaxis have been reported) Side Effects: GI Adverse events: nausea, vomiting, constipation, diarrhea (~5-15%) most GI side side effects occur during dose initiation or escalation and wane after a few weeks (Drucker, 2024)
This increases reliance on independent verification or community reports
The question is whether we build the practice around it
This is the FDA-approved Wegovy pill, not a compounded oral tablet from our best compounded semaglutide program lineup
